adlbioantur

/Tag:adlbioantur
­

ADL Bionatur Solutions Raises € 12 million with Institutional Investors

Capital Raise Follows Successful Listing at the Spanish Mercado Alternativo Bursátil (MAB) through a Reverse Acquisition of Bionaturis by ADL Biopharma

León, Spain, 30 July 2018: ADL Bionatur Solutions (MAB: ADL), a company specialized in research and development of health products, services and industrial fermentation production, today announced the closing of a € 12 million fund raising with institutional and qualified investors in Spain. The transaction follows the listing in May 2018 on the Mercado Alternativo Bursátil (MAB) a sub-market of the Spanish Prime Market (BME), through a reverse acquisition of Bionaturis by ADL Biopharma.

On 19 July 2018, ADL’s Board of Directors set a price per share to € 2.20 for the € 12 million capital increase with qualified investors, excluding subscription rights. Under the transaction, ADL issued 5,454,546 new shares, which are issued and listed on 30 July. ADL´s freefloat has now increased to over 20 %, thus its main shareholder Black Toro Capital (BTC) now holds 73,23 %, while Víctor Infante, founder of Bionaturis, holds 5,08 % of the Company.

Pilar de la Huerta, CEO of ADL Bionatur Solutions commented: “We are very proud to be trusted by so many major funds and investors. This financing supports our confidence in the strategy and future growth of the Company, shared with the investors during the fund raising. I would like to thank both the teams at ADL Bionatur Solutions and BTC plus our external consultants for their great efforts during these months.”

In light of the transaction, Banco Sabadell valued the average price of the Company shares at € 3.52 each, representing a potential upside of 60 % compared to the offer price. Furthermore, GVC Gaesco, a Spanish Investment bank, recently initiated coverage of ADL.

Impulsa is acting […]

July 30th, 2018|Blog english, Press Releases|Comments Off on ADL Bionatur Solutions Raises € 12 million with Institutional Investors

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

CERRAR